Boryung resupplies Buspar tablets

Published: 2007-05-10 06:57:00

Updated: 2007-05-10 06:57:00

Boryung Pharm said on May 8 that it has resupplied, through BMS Korea, Buspar (buspirone HCl) tablets 5 mg and 10 mg, an anxiolytic agent and a serotonin receptor agonist belonging to the azaspirodecanedione class of compounds, from April 30 after obtaining an approval of some process modificatio...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK